IP Verse

Merck Sharp & Dohme Llc competitive analysis

Latest oppositions filed by Merck Sharp & Dohme Llc

Explore patent oppositions filed by Merck Sharp & Dohme Llc against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP3820906
Multi-Specific Wnt Surrogate Molecules And Uses ThereofSURROZENJul 15, 2026
EP4223311
Individualized Vaccines For CancerBIONTECHMar 18, 2026
EP3635408
Methods For Predicting The Usefulness Of Disease Specific Amino Acid Modifications For ImmunotherapyBIONTECHJan 30, 2026
EP3597659
Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECHDec 1, 2023
EP3597216
Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses ThereofE R SQUIBB & SONSApr 27, 2023
EP3760715
Large-Scale Production Of Soluble HyaluronidaseHALOZYMEMay 4, 2022
EP3322731
Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBBOct 12, 2021
EP2382228
Compositions And Methods Of Treating Inflammatory And Autoimmune DiseasesAMGENMay 26, 2021
EP2949666
Human Anti-Alpha-Synuclein AntibodiesBIOGEN NEUROSCIENCESep 19, 2019
EP1810026
B7-H1 And Methods Of Diagnosis, Prognosis, And Treatment Of CancerMAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCHJan 16, 2019

Latest patents of Merck Sharp & Dohme Llc opposed by its competitors

Explore Merck Sharp & Dohme Llc's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3752180
Jul 22, 2026Methods For Treating Cancer With Anti-Pd-1 Antibodies2
EP3576759
Sep 24, 2025Methods For Production Of Capsular Polysaccharide Protein Conjugates From Streptococcus Pneumoniae Serotype 19F2
EP2893929
Apr 16, 2025Ceftolozane Antibiotic Compositions1
EP3165220
Nov 13, 2024Pharmaceutical Composition Containing An Anti-Nucleating Agent3
EP3616695
Oct 23, 2024Methods For Treating Intrapulmonary Infections1
EP3283882
Oct 16, 2024Blood-Based Biomarkers Of Tumor Sensitivity To Pd-1 Antagonists1
EP3678654
Jun 26, 2024Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein Conjugates3
EP3498734
Sep 1, 2021Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer7
EP3391890
Aug 25, 2021Posaconazole Intravenous Solution Formulations Stabilized By Substituted Beta-Cyclodextrin4
EP2970916
Apr 14, 2021Adapted Lepidopteran Insect Cells For The Production Of Recombinant Proteins2

Latest PTAB cases involving Merck Sharp & Dohme Llc

Discover the latest PTAB cases involving Merck Sharp & Dohme Llc, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Merck Sharp & Dohme Llc with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MERCK SHARP & DOHME2349615
GENENTECH - 115 - 66
KONIG SZYNKA TILMANN VON RENESSE34 - - -
PAJARO30 - - -